S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAIVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED CLL12 TRIAL

ABSTRACT:

SUBMITTER: Langerbeins P 

PROVIDER: S-EPMC10428394 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature